NanoRAD is a safe, long lasting residual disinfectant that helps healthcare facilities reduce the chance of Hospital Acquired Infections (HAIs) from surfaces.
Primary Application Area: Healthcare & Medical Devices
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
Vetted Programs/Awards: NanoRAD received a Phase I STTR, our research team was named "South Florida Health Care Innovators of 2020", and Kismet Technologies was accepted into the Mass Challenge (Texas - Health Tech) Accelerator for NanoRAD.
Organization Type: Early-stage Startup (Seed)
GOVT/EXTERNAL FUNDING SOURCES
External Funding to Date: Angel investment: $250k (Feb 2021)